|
Hormone (unit) |
PCOS Patients(n=28) |
Controls(n=14) |
P value |
| Pre-Gn stimulation level |
LH (mIU/ml) |
6.9±3.3 (1.7-13.7) |
4.7±1.3 (2.6-6.2) |
0.1288 |
| FSH (mIU/ml) |
6.7±1.7 (2.6-9.1) |
8.1±1.1 (6.4-9.7) |
0.0441 |
| E2 (pg/ml) |
54.3±23.0 (28.5-115.1) |
47.3±22.0 (29.2-93.4) |
0.4802 |
| P (ng/ml) |
0.5±0.2 (0.2-1.0) |
0.4±0.2 (0.2-0.6) |
0.4985 |
| PRL (ng/ml) |
14.0±8.9 (5.3-40.6) |
14.9±4.3 (8.0-20.3) |
0.7905 |
| T (ng/dl) |
53.0±25.9 (18.0-114.3) |
35.8±11.5 (19.7-48.0) |
0.1051 |
| Gn treatment |
Gn Dose(IU) |
2652±1020 (1275-5850) |
3117±745.5 (1900-4278) |
0.2353 |
| Duration (Day) |
11.0±2.1 (7-15) |
10.4±1.3 (8-12) |
0.1022 |
| Pre-HCG stimulation level |
LH (mIU/ml) |
2.8±6.6 (0.2-26.8) |
2.2±1.8 (0.3-6.7) |
0.7546 |
| E2 (pg/ml) |
3180±1258 (531.1-4800) |
3462±1185 (1149-4800) |
0.4886 |
| P (ng/ml) |
1.4±1.4 (0.2-5.8) |
1.2±0.7 (0.3-2.4) |
0.5529 |
| LH: luteinizing hormone; FSH: follicle-stimulating hormone; E2: estradiol; P: progesterone; PRL: prolactin; T: testosterone. |
|
